Leads Biolabs Receives Orphan Drug Designation from the US FDA for LBL-034, a Uniquely Designed, Highly Differentiated Anti-GPRC5D/CD3 Bispecific Antibody, for the Treatment of Multiple Myeloma
NANJING, China, Nov. 6, 2024 /PRNewswire/ — On November 1, Nanjing Leads…
October 2024 Global Sources Hong Kong Shows Conclude, Innovation Drives New Trends in Global Trade, Multiple Shows Combine to Boost Global Trade Development
HONG KONG, Nov. 6, 2024 /PRNewswire/ — The October 2024 Global Sources…